Synaptoporin 抗体 (AA 31-130)
(1 reference)-
- 抗原 See all Synaptoporin (SYNPR) 抗体
- Synaptoporin (SYNPR)
-
抗原表位
- AA 31-130
-
适用
- 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Synaptoporin antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 交叉反应
- 大鼠
- 预测反应
- Human,Mouse
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human Synaptoporin.
- 亚型
- IgG
- Top Product
- Discover our top product SYNPR Primary Antibody
-
anti-Synaptoporin (SYNPR) (AA 199-265) antibody
SYNPR 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Synaptoporin (SYNPR) antibodySYNPR 适用: 大鼠, 小鼠, Hamster WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Synaptoporin (SYNPR) (C-Term) antibodySYNPR 适用: 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Synaptoporin (SYNPR) antibodySYNPR 适用: 大鼠, 小鼠, Hamster WB, ICC, IP 宿主: 豚鼠 Polyclonal unconjugated
anti-Synaptoporin (SYNPR) (Middle Region) antibodySYNPR 适用: 人, 大鼠, 小鼠, Cow, 犬, 豚鼠, 马, 兔, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
-
: "The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 192, pp. 317-24, (2014) (PubMed).
-
: "The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 192, pp. 317-24, (2014) (PubMed).
-
-
